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Figure S1: Representative autoradiogram of the EMSA assay to determine binding affinity of p53′ to synthetic consensus sequence 
oligonucleotides.   The AQ-AAA sequence is used in the EMSA above.  The left two lanes are single stranded oligo (SS) and double stranded 
oligo (DS), respectively. The following lanes are a serial dilution of p53′ starting ranging from 3.2 µM to 6.25 nM.  Samples contained 100 nM 
AQ-AAA, 5 µM dAdT, 0.1% NP-40, 0.1 mg/ml BSA in 20 mM TrisCl (pH 8), 20% glycerol, 100 mM KCl, and 0.2 mM EDTA.  Image quant 
was used to analyze the signal intensities for each band.  A minimum of three replicates per sequence was conducted.  The data were fit to the Hill 
equation in Origin and the concentration of p53′ (in monomer units) at which the DNA is half maximally bound was determined.    
  
 























































































































































































































































Figure S2: Representative 
autoradiograms of the guanine oxidation 
gel shift assays of the AQ-conjugated 
synthetic consensus sequence 
oligonucleotides with a 3′ radiolabel. 
Lanes 1 and 2 are the Maxam-Gilbert 
sequencing lanes corresponding to 
pyrimidies (C/T) and purines (A/G). 
Individual bases are designated on the 
left along with the parent band (P) and 
the crosslinked bands (XL).  The dark 
control in lane 3 was not irradiated and 
contained no p53′. The following lanes 
4-9 are irradiated samples with varied 
concentrations of p53′ from 0 to 40 µM 
of p53′ monomer respectively.  Samples 
contained 1 µM AQ-Duplex, 5 µM 
dAdT, 0.1% NP-40, 0.1 mg/ml BSA in 
20 mM TrisCl (pH 8), 20% glycerol, 
100 mM KCl, and 0.2 mM EDTA. 
Ethanol precipitated samples were 
suspended in formamide loading dye 
and run on a pre-run 20% 
polyacrylamide denaturing gel at 90 
watts for three hours in 1x TBE buffer. 
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Supporting Table S1:  























∆ gene regulation Reference 
AIFM2 AGGCA TGAGC CACCGTGCCT GGCCA AGCCC AIFM2 
Activator Dissociation Downregulation 1 
 
Yes Yes Traps Yes Yes Yes 
APAF1 AGACA TGTCT GGAGACCCTAGGA CGACA AGCCC APAF1 
Activator Dissociation Downregulation 2 
 
No No Traps No Yes No 
BBC3 CTGCA AGTCC 
 
TGACT TGTCC BBC3 




No Yes Yes 
C12orf5 AGACA TGTCC AC AGACT TGTCT C12orf5 




No No No 
CCNK AAACT AGCTT GC AGACA TGCTG CCNK 




No Yes Yes 
CDKN1A GAACA TGTCC 
 
CAACA TGTTG CDKN1A 




No No No 
DDB2 GAACA AGCCC T GGGCAT TGTTT DDB2 




Yes No Yes 
FAS GGACA AGCCC 
 
TGACA AGCCA FAS 




No Yes Yes 
GADD45A GAACA TGTCT 
 
AAGCAT TGCTG GADD45A 




Yes Yes Yes 
IGFBP3 AAACA AGCCA C CAACA TGCTT IGFBP3 




No Yes Yes 
MMP2 AGACA AGCCT 
 
GAACT TGTCT MMP2 




No No No 
PERP AGGCA AGCTC 
 
CAGCT TGTTC PERP 




Yes No Yes 
PLK2 AAACA TGCCT  GGACT TGCCC PLK2 
Activator Dissociation Downregulation 13 





PPM1J GAACA TGCCT 
 
GAGCA AGCCC PPM1J 




Yes Yes Yes 
PTEN GAGCA AGCCC CAGGCAGCTACACT GGGCA TGCTC PTEN 
Activator Dissociation Downregulation 15 
 
Yes Yes (No) Traps Yes Yes Yes 
RRM2B TGACA TGCCC 
 
AGGCA TGTCT RRM2B 




Yes No Yes 
SCARA3 GGGCA AGCCC 
 
AGACA AGTTG SCARA3 




No No Yes 
TP63 TAACT TGTTA TTG AAACA TGCTC TP63 




No Yes No 
TSC2 TAACA AGCTC G GGGCT AGCCC TSC2 
Activator Dissociation Downregulation 19 
 
No Yes Trap (No) Yes Yes Yes 
VCAN AGACT TGCCA C AGACA AGTCC VCAN 




No Yes Yes 
VDR TAACT AGTTT 
 
GAACA AGTTG VDR 




No No No 
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